The settlement benefits anyone who classifies within the six classes of third-party payors. You may be eligible for a potential award from the Nexium, Diovan, Valcyte Price Fixing Class Action Lawsuit!
According to the class action, the companies worked together to fix the price of generic Nexium and generic or branded Diovan and Valcyte. So if you are eligible, file a claim by October 11, 2022 to receive your potential award!
Nexium, Diovan, Valcyte Price Fixing CAL
- Claim Form Deadline: October 11, 2022
- Who’s Eligible: The settlement establishes six classes of third-party payors:
- Generic Nexium Nationwide Class: Those who purchased or paid for some or all of the purchase price of AB-rated generic versions of Nexium in the U.S. and its territories between May 27, 2014, and Feb. 1, 2019
- Generic Nexium State Law Class: Those who purchased or paid for some or all of the purchase price of AB-rated generic versions of Nexium between May 27, 2014, and Feb. 1, 2019, in Arizona, California, the District of Columbia, Florida, Hawaii, Iowa, Massachusetts, Maine, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, North Carolina, North Dakota, Oregon, South Dakota, Vermont, West Virginia and Wisconsin
- Brand or Generic Diovan Nationwide Class: Those who purchased or paid for some or all of the purchase price of Diovan and/or AB-rated generic versions in the U.S. or its territories between Sept. 28, 2012, and April 1, 2020
- Brand or Generic Diovan State Law Class: Those who purchased or paid for some or all of the purchase price of Diovan or AB-rated generic versions from Sept. 28, 2012, through April 1, 2020, in Arizona, California, the District of Columbia, Florida, Hawaii, Iowa, Massachusetts, Maine, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, North Carolina, North Dakota, Oregon, South Dakota, Vermont, West Virginia and Wisconsin
- Brand or Generic Valcyte Nationwide Class: Those who purchased or paid for some or all of the purchase price of Valcyte or AB-rated generic versions of Valcyte from Aug. 1, 2014, through April 1, 2020, in the U.S. or its territories
- Brand or Generic Valcyte State Law Class: Those who purchased or paid for some or all of the purchase price of AB-rated generic versions of Valcyte from Aug. 1, 2014 through April 1, 2020, in Arizona, California, the District of Columbia, Florida, Hawaii, Iowa, Massachusetts, Maine, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, North Carolina, North Dakota, Oregon, South Dakota, Vermont, West Virginia and Wisconsin
- Estimated Amount: TBD
- Proof of Purchase: Related transaction data and any other claim documentation, such as invoices, supporting your claim in case the settlement administrator requests it later
- Case Name & Number: In re: Ranbaxy Generic Drug Application Antitrust Litigation, Case No. 19-MD-02878-NMG in the U.S. District Court District of Massachusetts
(Click here to file a claim)
How To File a Claim
- Head over to the Nexium, Diovan, Valcyte Price Fixing Claim Form.
- Read over the claim form to see if you are eligible.
- Complete the claim form with your info.
- Submit your claim form to receive your potential award by October 11, 2022!
Bottom Line
The settlement benefits anyone who classifies within the six classes of third-party payors. You may be eligible for a potential award from the Nexium, Diovan, Valcyte Price Fixing Class Action Lawsuit!
If you are eligible, file a claim by the deadline to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements! Be sure to give our list of No-Proof Class Action lawsuit to see other settlements you may qualify for.
The post Nexium, Diovan, Valcyte Price Fixing Class Action Lawsuit appeared first on Hustler Money Blog.